title: Does memantine improve the gait of individuals with Alzheimer's disease?
authors.forename: Olivier
authors.initials: O
authors.lastname: Beauchet
authors.forename: Gilles
authors.initials: G
authors.lastname: Allali
authors.forename: Cyrille
authors.initials: C
authors.lastname: Launay
authors.forename: Bruno
authors.initials: B
authors.lastname: Fantino
authors.forename: Cédric
authors.initials: C
authors.lastname: Annweiler
mesh_terms: D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005684:Gait / Q000187:drug effects*; D020233:Gait Disorders, Neurologic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D008559:Memantine / Q000627:therapeutic use*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D018691:Excitatory Amino Acid Antagonists; D008559:Memantine